LTGO

Latigo Biotherapeutics, Inc.

Healthcare · Biotechnology

14.80$ -4.7% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LTGO
Line item	Q1 25	Q2 25	Q1 26	Q2 26
Revenue	–	–	0.00	0.00
Research & Development	–	–	0.29	0.35
Selling, General & Administrative	–	–	0.10	0.08
Total Operating Expenses	–	–	0.39	0.43
Operating Income	–	–	-0.39	-0.43
Interest Expense	–	–	–	0.00
Pre-Tax Income	–	–	-0.38	-0.43
Net Income	–	–	-0.38	-0.43
EBITDA	–	–	-0.39	-0.42

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.